• TSPAN18 Protects STIM1 to Drive Prostate Cancer Bone Metasta

  2026-05-08

  Zhou et al. identified a novel mechanism where TSPAN18 stabilizes STIM1 by inhibiting its TRIM32-mediated ubiquitination, thereby enhancing store-operated calcium entry (SOCE) and facilitating bone metastasis in prostate cancer. This work provides mechanistic insight into the calcium signaling pathway as a driver of metastatic progression, highlighting TSPAN18 as a potential therapeutic target with translational relevance.

• Chloroquine’s Mechanisms and Applications in Cancer Therapy

  2026-05-07

  This review systematically analyzes how chloroquine, a classic antimalarial and anti-inflammatory compound, exerts antitumor effects through both autophagy-dependent and independent pathways. By consolidating mechanistic insights and emerging pharmacological data, the study provides a framework for advancing chloroquine's clinical and preclinical applications in oncology.

• ZCL278: Selective Cdc42 Inhibitor for Cell Motility and Fibr

  2026-05-07

  Harness the precision of ZCL278, a selective Cdc42 inhibitor, to dissect cell motility, branching, and fibrotic signaling in cutting-edge research models. This guide bridges practical protocol optimization with recent breakthroughs in Cdc42 targeting, empowering reliable, reproducible results across cell biology and disease research.

• CDC42-YAP-mTOR Axis Shapes Intestinal Stem Cell Fate via Pol

  2026-05-06

  This study uncovers how CDC42-mediated epithelial polarity orchestrates the fate transition from intestinal stem cells to transit amplifying cells through the YAP-EGF-mTOR signaling cascade. The findings reframe our understanding of cell fate regulation and proliferation in the intestinal crypt, with direct implications for disease modeling and targeted pathway inhibition.

• GSK J4 HCl: JMJD3 Inhibitor for Epigenetic Regulation Workfl

  2026-05-06

  GSK J4 HCl offers researchers a highly cell-permeable, potent JMJD3 inhibitor to dissect histone demethylation and inflammation pathways. This guide delivers actionable protocols, troubleshooting strategies, and real-world use cases, with insights anchored in translational research and cutting-edge epigenetic studies.

• Viral Disruption of FPN1-Mediated Iron Homeostasis Weakens H

  2026-05-05

  This study uncovers how viruses subvert the host’s iron withholding mechanism by promoting ferroportin (FPN1) degradation, elevating cellular iron and suppressing key antiviral responses. The work identifies a virus-driven pathway involving DTX3L-mediated FPN1 ubiquitination, revealing new insight into host-pathogen interactions and iron-dependent immune regulation.

• Comparative Antibacterial Activity of Cefoperazone and New β

  2026-05-05

  This article examines a landmark study comparing the antibacterial profiles of N-formimidoyl thienamycin (MK0787) with several recently developed β-lactam antibiotics, including cefoperazone, across a wide spectrum of clinical isolates. The analysis highlights key findings relevant to gram-negative resistance and informs optimal antibiotic selection for advanced in vitro research.

• Sildenafil Citrate: Proteoform-Specific Assay Design & Insig

  2026-05-04

  Explore how Sildenafil Citrate, a cGMP-specific phosphodiesterase type 5 inhibitor, enables advanced proteoform-resolved research. This article reveals cutting-edge assay considerations and practical applications in vascular biology that go beyond current reviews.

• Rapamycin (Sirolimus): Applied mTOR Inhibition in Cell Biolo

  2026-05-04

  Rapamycin (Sirolimus) delivers precise, nanomolar-targeted mTOR inhibition for advanced studies in cancer, immunology, and neurodegeneration. This guide translates bench research and reference breakthroughs into optimized workflows, troubleshooting strategies, and real-world assay enhancements for maximum experimental impact.

• IL-17A as a Prognostic Marker in GBS-Colonized Pregnancies

  2026-05-03

  This study identifies low maternal IL-17A levels as a significant prognostic biomarker for neonatal risk following Group B Streptococcus (GBS) colonization. Through clinical cohort analysis and ex vivo immune stimulation, the research delineates the role of TLR1/2-mediated cytokine responses in maternal-neonatal immunity, offering new translational insights for predicting invasive GBS disease.

• Practical Guide: Cell Counting Kit-8 (CCK-8) Plus in Assays

  2026-05-02

  Cell Counting Kit-8 (CCK-8) Plus addresses the demand for rapid, sensitive cell proliferation and cytotoxicity measurement in research workflows where accurate quantification of viable cells is critical. It is suitable for high-throughput cytotoxicity screening, proliferation studies, and dehydrogenase activity measurement, but should not be used for non-cell-based assays or where endpoint quantification is incompatible with WST-8 chemistry.

• Ruthenium Red in Mechanotransduction: Precision Tools for Ca

  2026-05-01

  Explore Ruthenium Red as a Ca2+ transport inhibitor in mechanotransduction and autophagy research. This article uniquely bridges quantitative biophysical insights with practical assay design, offering new perspectives for calcium signaling research.

• HCN4 Channels Mediate Cardiac Heat Response via S4-S5 Motif

  2026-05-01

  This study uncovers a molecular mechanism by which HCN4 channels in cardiac pacemaker cells directly sense temperature through a conserved S4-S5 linker motif, mediating heart rate acceleration in response to heat. The findings redefine our understanding of thermal regulation in vertebrate cardiac physiology and suggest broader implications for ion channel thermosensitivity.

• Alternariol in Fungal Toxin Study: Mechanisms, Metabolism, a

  2026-04-30

  Explore the multifaceted role of Alternariol (AOH) in mycotoxin research, with a focus on its unique mechanisms of action, cytochrome P450-mediated metabolism, and practical assay considerations. This article delivers advanced context for researchers aiming to leverage AOH in complex biological systems.

• Ruthenium Red: Precision Ca2+ Transport Inhibitor in Cell As

  2026-04-30

  Ruthenium Red from APExBIO is the gold-standard Ca2+ transport inhibitor for dissecting cytoskeleton-dependent calcium signaling and mechanotransduction workflows. This guide translates recent breakthroughs into actionable steps, optimizing both autophagy and inflammation research with robust troubleshooting and protocol detail.

358 records 6/24 page Previous Next First page 上5页 678910 下5页 Last page